Northern Trust
JUNS

Northern Trust’s Jupiter Neurosciences JUNS Stock Holding History

Northern Trust’s Portfolio JUNS Stock Details JUNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.54K Hold
25,346
– – ﹤0.01% 4375
2025
Q4 		$25.9K Buy
25,346
+527
+2% +$701 ﹤0.01% 4366
2025
Q3 		$43.7K Buy
+24,819
New +$37.6K ﹤0.01% 4298

Other funds holding JUNS

VC
Vestor Capital Chicago, Illinois $1.38B AUM 39.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
YAG
Yorkville Advisors Global Mountainside, New Jersey $155M AUM 58.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MB
MidFirst Bank Oklahoma City, Oklahoma $1.21B AUM

Northern Trust's JUNS Position: Q1 2026 in Review

Northern Trust held its Jupiter Neurosciences (JUNS) position steady in Q1 2026 at 25,346 shares worth $9.54K. The position accounts for ﹤0.01% of the portfolio, ranked #4375.

Northern Trust first reported a position in JUNS in Q3 2025 and has held it in 3 quarters since. The position peaked at $43.7K in Q3 2025. 10 funds tracked by Wall St. Rank hold JUNS as of Q1 2026.

  • Northern Trust held 25,346 shares of Jupiter Neurosciences worth $9.54K as of Q1 2026.
  • Northern Trust left its Jupiter Neurosciences share count unchanged in Q1 2026.
  • Jupiter Neurosciences made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4375 holding.
  • Northern Trust first reported a position in Jupiter Neurosciences in Q3 2025 and has held it in 3 quarters since.
  • Northern Trust's Jupiter Neurosciences position peaked at $43.7K in Q3 2025.
  • 10 funds tracked by Wall St. Rank held Jupiter Neurosciences as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.